News & events

Pascale Bouillé, CEO of Vectalys and president at FlashCell, was at the "Bioproduction des immunothérapies en France" conference at Biocitech Romainville on 09-26-2017 to talk about our new generation of RNA delivery particle and its applications in gene editing and immunotherapy.

The FlashCell team looks forward to sharing its recent data about LentiFlash™ for genome-editing and immunotherapy approaches at the ESGCT 2017.

Vectalys is proud to launch FlashCell, a new gene therapy company specialized in the development of RNA carriers for therapeutic applications.